Cargando…

Efficacy and Safety of Initial Combination Therapy in Treatment-Naïve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis

INTRODUCTION: The aim of this study was to evaluate the efficacy and safety of initial combination therapy compared with monotherapy in drug-naïve type 2 diabetes patients. METHODS: MEDLINE, Embase and the Cochrane Central Register of Controlled Trials were searched for randomized clinical trials of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Xiaoling, Gao, Xueying, Yang, Wenjia, Han, Xueyao, Ji, Linong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167297/ https://www.ncbi.nlm.nih.gov/pubmed/30155646 http://dx.doi.org/10.1007/s13300-018-0493-2

Ejemplares similares

Baseline Body Mass Index and the Efficacy of Hypoglycemic Treatment in Type 2 Diabetes: A Meta-Analysis
por: Cai, Xiaoling, et al.
Publicado: (2016)

Meta‐analysis and critical review on the efficacy and safety of alpha‐glucosidase inhibitors in Asian and non‐Asian populations
por: Gao, Xueying, et al.
Publicado: (2017)

No disparity of the efficacy and all‐cause mortality between Asian and non‐Asian type 2 diabetes patients with sodium–glucose cotransporter 2 inhibitors treatment: A meta‐analysis
por: Cai, Xiaoling, et al.
Publicado: (2017)

Clinical Characteristics of Young Type 2 Diabetes Patients with Atherosclerosis
por: Yang, Wenjia, et al.
Publicado: (2016)

Addition of dipeptidyl peptidase‐4 inhibitors to insulin treatment in type 2 diabetes patients: A meta‐analysis
por: Yang, Wenjia, et al.
Publicado: (2017)

Evaluation of efficacy and safety of glucokinase activators—a systematic review and meta-analysis
por: Yang, Wenjia, et al.
Publicado: (2023)

Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Cai, Xiaoling, et al.
Publicado: (2021)

Comparisons of the Efficacy of Alpha Glucosidase Inhibitors on Type 2 Diabetes Patients between Asian and Caucasian
por: Cai, Xiaoling, et al.
Publicado: (2013)

Comparisons of weight changes between sodium‐glucose cotransporter 2 inhibitors treatment and glucagon‐like peptide‐1 analogs treatment in type 2 diabetes patients: A meta‐analysis
por: Cai, Xiaoling, et al.
Publicado: (2017)

The Body Weight Alteration and Incidence of Neoplasm in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
por: Lin, Chu, et al.
Publicado: (2020)

Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trials
por: Hu, Suiyuan, et al.
Publicado: (2022)

Analysis of Insulin Doses of Chinese Type 2 Diabetic Patients with Intensive Insulin Treatment
por: Cai, Xiaoling, et al.
Publicado: (2012)

Reduction of C-reactive protein, low-density lipoprotein cholesterol, and its relationship with cardiovascular events of different lipid-lowering therapies: A systematic review and meta-analysis of randomized controlled trials
por: Yang, Wenjia, et al.
Publicado: (2022)

Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study
por: Lim, Soo, et al.
Publicado: (2020)

Relationship Between Gestational Weight Gain and Pregnancy Complications or Delivery Outcome
por: Yang, Wenjia, et al.
Publicado: (2017)

Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysis
por: Hu, Suiyuan, et al.
Publicado: (2023)

Analysis of the Associations between Vitamin D and Albuminuria or β-Cell Function in Chinese Type 2 Diabetes
por: Cai, Xiaoling, et al.
Publicado: (2014)

Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon‐Like Peptide‐1 Receptor Agonist and Sodium‐Glucose Cotransporter‐2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta‐Analysis
por: Hu, Mengdie, et al.
Publicado: (2020)

Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus
por: Lin, Chu, et al.
Publicado: (2020)

A Decision-Support Software to Improve the Standard Care in Chinese Type 2 Diabetes
por: Luo, Yingying, et al.
Publicado: (2019)

Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of Diabetes
por: Wang, Yanai, et al.
Publicado: (2019)

Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes
por: Cai, Xiaoling, et al.
Publicado: (2022)

Generalizability of the Results of Cardiovascular Outcome Trials of Glucagon-Like Peptide 1 Receptor Agonists in Chinese Patients with Type 2 Diabetes Mellitus
por: Cai, Xiaoling, et al.
Publicado: (2021)

Baseline Triglyceride Level Affected the Efficacy of Vildagliptin in Treating Type 2 Diabetes: A Post Hoc Analysis of the VISION Study
por: Zhou, Lingli, et al.
Publicado: (2019)

Serum Albumin, but not Bilirubin, is Associated with Diabetic Chronic Vascular Complications in a Chinese Type 2 Diabetic Population
por: Zhu, Yu, et al.
Publicado: (2019)

Age at Diagnosis and C-Peptide Level Are Associated with Diabetic Retinopathy in Chinese
por: Cai, Xiaoling, et al.
Publicado: (2014)

SGLT2 inhibitors and lower limb complications: an updated meta‐analysis
por: Lin, Chu, et al.
Publicado: (2021)

Correction to: SGLT2 inhibitors and lower limb complications: an updated meta-analysis
por: Lin, Chu, et al.
Publicado: (2021)

Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Double-Blind Randomized Trial
por: Ji, Linong, et al.
Publicado: (2015)

P38 Plays an Important Role in Glucolipotoxicity-Induced Apoptosis in INS-1 Cells
por: Zhou, Lingli, et al.
Publicado: (2014)

The association between metabolic parameters and evening chronotype and social jetlag in non-shift workers: A meta-analysis
por: Zhang, Rui, et al.
Publicado: (2022)

Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2010)

Efficacy and safety of premixed insulin analogs in Asian patients with type 2 diabetes: A systematic review
por: Sheu, Wayne H‐H, et al.
Publicado: (2017)

The genetic and clinical characteristics of WFS1 related diabetes in Chinese early onset type 2 diabetes
por: Li, Yating, et al.
Publicado: (2023)

Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
por: Cai, Xiaoling, et al.
Publicado: (2020)

Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study
por: Liu, Wei, et al.
Publicado: (2020)

Clinical and Genetic Characteristics of ABCC8 Nonneonatal Diabetes Mellitus: A Systematic Review
por: Li, Meng, et al.
Publicado: (2021)

Rs4074134 Near BDNF Gene Is Associated with Type 2 Diabetes Mellitus in Chinese Han Population Independently of Body Mass Index
por: Han, Xueyao, et al.
Publicado: (2013)

Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin‐naïve people with type 2 diabetes: The EDITION AP randomized controlled trial
por: Ji, Linong, et al.
Publicado: (2019)

Efficacy and safety of fixed‐dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial
por: Ji, Linong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kfkoiu2tkd2m277319rqi0sj6f